May 21, 2012

Attention Health Care Providers: Are You in Violation of the Stark Act?

An emerging case out of South Carolina may have a far-reaching impact on health care providers across the country. Health care providers have long been aware of the penalties for violating the Stark Law, only now violating the Stark Law may also bring False Claims Act charges and additional penalties that include treble damages.

The Stark Law and the False Claims Act

The Stark Law1 generally prohibits a physician from making referrals for designated health services that will be payable by Medicare or Medicaid where the referral is to an entity in which the physician or an immediate family member has a financial relationship. The financial interest may be direct ownership, investment, or a structured compensation arrangement. The Stark Law is a strict liability statute - any violation, whether intended or not, will receive penalties. In contrast, the False Claims Act ("FCA")2 creates liability for anyone who knowingly submits or causes the submission of a false or fraudulent claim to the United States. Penalties can include not only reimbursement but also triple damages, penalties ranging from $5,500 to $11,000 per claim, and possible exclusion from all federal health care programs. Due to the high dollar value of potential damages, many FCA cases settle out of court and new case law explaining the FCA is rare.

The Tuomey Case

Tuomey is a nonprofit community hospital in South Carolina. Having built an Outpatient Surgery Center, the hospital was concerned that its doctors would move their outpatient procedures to other facilities. Tuomey sought the advice of legal counsel which advised the hospital it had a legal duty to protect the corporation's assets and recommended offering part-time contracts to physicians. Counsel advised that these contracts would violate neither the Stark Law nor the FCA. One of the physicians offered a contract, however, filed aqui tam3 complaint alleging Tuomey violated both laws by providing compensation in excess of fair market value and that took into account the volume or value of the referrals or other business the physicians generated.4 The Department of Justice intervened in the lawsuit. Intervention by the Department of Justice only occurs after an extensive review process and occurs in less than 25% of FCA qui tam cases.5

In March 2010, the jury returned with a split verdict. It found Tuomey's part-time physician contracts violated the Stark Law but did not violate FCA. But the judge overturned the jury's ruling for Tuomey on the FCA claims. The re-trial of the FCA claims is likely to occur this fall while the appeal of the Stark Law claims is likely to be heard in the spring. The appeals court will decide whether Tuomey must pay Stark Law damages of $44.8 million plus interest, for a total of $49.3 million. The new jury will decide whether Tuomey must pay FCA damages of $277.5 million in the FCA retrial.

Analysis

The Tuomey case may well signal a new and emerging tactic of the United States Department of Justice in its "war on health care fraud" and may have far reaching impact beyond South Carolina. Violations of the Stark Act may increasingly be used as a predicate for FCA violations in future cases brought by the United States Department of Justice throughout the country. Linking violations of these two laws that carry hefty penalties will undoubtedly increase the stakes for violations of the Stark Act. In light of this emerging trend, health care providers would be wise to consult with legal counsel to review their contracts and practices for any potential impact from this case.

____________________

(1) 42 U.S.C. 1395nn (2010). 
(2) 31 U.S.C. § 3729-3733 (2010). 
(3) A qui tam lawsuit is an action brought under statute that allows a private person to sue for a penalty, part of which the government will receive and part of which the person bringing the action will receive. Generally under the FCA, whistleblowers bring qui tam actions. 
(4) U.S. ex rel Drakeford v. Tuomey Healthcare System, Inc., Civ. No. 3:05-2858 (D.S.C.). 
(5) For more information on the Department of Justice's role in FCA qui tam actions, see False Claims Act Cases: Government Intervention in Qui Tam (Whistleblower) Suits,http://www.justice.gov/usao/pae/Documents/fcaprocess2.pdf.

© 2012 Dinsmore & Shohl LLP. All rights reserved.

About the Author

Partner

D. Michael Crites is a Partner in the Litigation Department. Mr. Crites focuses his practice on federal court experience in complex civil litigation and white collar criminal matters, including healthcare fraud, Foreign Corrupt Practices Act compliance issues and Federal False Claims Act Violations. He has extensive experience in complex civil and criminal litigation, product liability defense of manufacturers and suppliers, fiduciary litigation, criminal tax and securities fraud defense, and business litigation involving contract disputes, copyright, trademark, trade secret...

614-628-6934

About the Author

Associate

Laura Hartnett is a member of the Litigation Department. She focuses her practice on general commercial litigation with an emphasis on health care and real estate law.

614-628-6930

Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. NLR does not accept advertising from attorneys or law firms. The National Law Review is not a law firm nor is www.NatLawReview.com  intended to be an advertisement or a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.